Clinical implications of ctDNA for EGFR-TKIs as first-line treatment in NSCLC. Liang X, Zhang W, Li J, Zhu J, et al. J Cancer Res Clin Oncol 2023;149:1211-1220.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liang X, Zhang W, Li J, Zhu J, et al. Clinical implications of ctDNA for EGFR-TKIs as first-line treatment in NSCLC. J Cancer Res Clin Oncol 2023;149:1211-1220.
PMID: 35380256